Skip to main content
. 2018 May 22;7(11):e008708. doi: 10.1161/JAHA.118.008708

Figure 7.

Figure 7

A, Cumulative 3‐year incidence of MI, ST, and ischemic stroke according to the thrombotic risk score categories in the derivation cohort. B, Cumulative 3‐year incidence of GUSTO moderate/severe bleeding according to the bleeding risk score categories in the derivation cohort. C, Cumulative 3‐year incidence of MI, ST, and ischemic stroke according to the thrombotic risk score categories in the validation cohort. D, Cumulative 3‐year incidence of GUSTO moderate/severe bleeding according to the bleeding risk score categories in the validation cohorts. GUSTO indicates Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries; MI, myocardial infarction; PCI, percutaneous coronary intervention; ST, definite or probable stent thrombosis.